Darbandi B, Noghbaei M, Mehrabian F, Jafroodi M
Pediatric Hematologist and Oncologist,: Pediatrics Growth Disorders Research Center, 17th Sharivar Hospital, Guilan University of Medical Sciences, Rasht, Iran.
Pediatrician, 31thKhordad Hospital, Manjil, Iran.
Iran J Ped Hematol Oncol. 2014;4(2):53-6. Epub 2014 Apr 20.
Glucose-6-phosphate dehydrogenase (G6PD) enzyme deficiency is one of the prevalent disorders in Guilan province, northern Iran, causing many patients to suffer from acute hemolysis. This disease has imposed tremendous costs both on patients and Health systems. The aim of this study was to compare the direct costs of favism treatment on patients and health system with G6PD enzyme screening test.
In this descriptive prospective study, the medical and hospital costs of acute hemolysis due to G6PD deficiency were calculated and compared with the expenses of screening newly born infants for this disorder in Rasht. Data was collected by a questionnaire.Student's t-Test and chi-squared test were recruited and data was analyzed using SPSS ver. 20.
In this study, 101 hospitalized patients with favism (72 male and 29 female) admitted from October 2011 to the end of September 2012 were included. The average cost of treatment for these patients was approximately 726000000Rials (for each patient 7190000 Rials), which was about half of the cost of screening for all newborn infants in Rasht during this period.
The cost of G6PD enzyme screening in Rasht is substantially lower than the cost of treating hospitalized patients with Favism.
葡萄糖-6-磷酸脱氢酶（G6PD）缺乏症是伊朗北部吉兰省常见的疾病之一，导致许多患者发生急性溶血。这种疾病给患者和卫生系统都带来了巨大的成本。本研究的目的是比较蚕豆病治疗对患者和卫生系统的直接成本与G6PD酶筛查试验的成本。
在这项描述性前瞻性研究中，计算了G6PD缺乏症导致的急性溶血的医疗和住院成本，并与拉什特市对新生儿进行该疾病筛查的费用进行了比较。通过问卷调查收集数据。采用学生t检验和卡方检验，并使用SPSS 20版软件进行数据分析。
本研究纳入了2011年10月至2012年9月底收治的101例蚕豆病住院患者（72例男性，29例女性）。这些患者的平均治疗费用约为7.26亿里亚尔（每位患者719万里亚尔），约为此期间拉什特市所有新生儿筛查费用的一半。
拉什特市G6PD酶筛查的成本远低于蚕豆病住院患者的治疗成本。
Zotero 插件
